The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

The process can be uncomfortable and interminable—but also lucrative.

List includes medications for diabetes, cancer, arthritis, and more ...

The 15 drugs selected for negotiation include Eli Lilly’s breast-cancer drug Verzenio.

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

The Centers for Medicare and Medicaid Services said Tuesday it seeks to lower Medicare costs for 16 medications by negotiating with their manufacturers. Among them is Biktarvy, a drug taken after HIV ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

CMS names medications 2028 for Medicare price negotiation, including Trulicity and Biktarvy, targeting high-cost drugs in ...

New research from the Center for Integration of Science and Industry at Bentley University shows that public companies with ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.